Yubei Huang
Overview
Explore the profile of Yubei Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji Y, Zhang Y, Duan H, Liu X, Zhang Y, Feng Z, et al.
Sci Rep
. 2025 Jan;
15(1):1927.
PMID: 39809769
Positive results from cancer screenings, like a cancer diagnosis, can increase the risk of cardiovascular disease (CVD) mortality due to heightened psychological stress. However, positive screening results may also serve...
2.
Shen A, Ye J, Zhao H, Qiang W, Zhao H, Huang Y, et al.
BMJ Open
. 2025 Jan;
14(12):e089769.
PMID: 39806613
Introduction: Lymphoedema is a distressing and long-term complication for breast cancer survivors. However, the reported incidence of lymphoedema varies, and its risk factors remain underexplored. Currently, a well-established risk prediction...
3.
Jin Q, Liu S, Zhang Y, Ji Y, Wu J, Duan H, et al.
Sci Rep
. 2025 Jan;
15(1):1472.
PMID: 39789183
Severe obesity is often associated with inflammation and insulin resistance (IR), which expected to increase the risks of mortality and cancers. However, this relationship remains controversial, and it's unclear whether...
4.
Duan H, Liu X, Zhang Y, Liu Y, Ji Y, Zhang Y, et al.
J Ovarian Res
. 2024 Oct;
17(1):210.
PMID: 39462415
Backgrounds: Cancer antigen 125 (CA125) is widely used for screening ovarian cancer (OC), yet its effectiveness remains debated. Potential factors may include ineffective cut-off value for CA125 in screening, as...
5.
Lyu Z, Zhang Y, Sheng C, Huang Y, Zhang Q, Chen K
Chin Med J (Engl)
. 2024 Sep;
137(21):2567-2576.
PMID: 39261986
Background: Thyroid cancer (TC) is the most common malignancy of the endocrine system. This study aimed to assess the global distribution of TC incidence and mortality in 2022, as well...
6.
Zhang Y, Sheng C, Fan Z, Liu Y, Liu X, Duan H, et al.
Prev Med
. 2024 Aug;
187:108117.
PMID: 39178994
Objective: To determine whether risk stratification can optimize the benefits of flexible sigmoidoscopy (FSG) screening. Methods: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial was conducted from 1993...
7.
Liu X, Duan H, Liu S, Zhang Y, Ji Y, Zhang Y, et al.
Front Genet
. 2024 Aug;
15:1387588.
PMID: 39149591
Background: Although the risk of prostate cancer (PCa) varies across different ages and genetic risks, it's unclear about the effects of genetic-specific and age-specific prostate-specific antigen (PSA) screening for PCa....
8.
Zhang Y, Sheng C, Lyu Z, Dai H, Song F, Song F, et al.
Cancer Biol Med
. 2024 Jun;
21(8).
PMID: 38899940
Objective: Few studies have evaluated the benefits of colorectal cancer (CRC) screening integrating both non-genetic and genetic risk factors. Here, we aimed to integrate an existing non-genetic risk model (QCancer-10)...
9.
Fan Z, Zhang Y, Yao Q, Liu X, Duan H, Liu Y, et al.
Front Oncol
. 2024 May;
14:1322044.
PMID: 38741776
Background: Although screening is widely used to reduce cancer burden, untargeted cancers are frequently missed after single cancer screening. Joint cancer screening is presumed as a more effective strategy to...
10.
Guan S, Sun J, Wang Y, Han S, Chen C, Yue D, et al.
Cancer Immunol Immunother
. 2024 May;
73(7):120.
PMID: 38713243
Purpose: The optimal treatment after neoadjuvant chemoimmunotherapy for patients with stage III non-small cell lung cancer (NSCLC) is unclear. This study aimed at comparing the efficacy and safety of chemoradiotherapy...